WASHINGTON – Engineers, optical and medical scientists, physicians, researchers, and graduate students will convene for this year’s Biophotonics Congress: Biomedical Optics in a hybrid format to be held 24 – 27 April, 2022 at the Westin Fort Lauderdale Beach Resort in Fort Lauderdale, Florida.
Credit: Optica
WASHINGTON – Engineers, optical and medical scientists, physicians, researchers, and graduate students will convene for this year’s Biophotonics Congress: Biomedical Optics in a hybrid format to be held 24 – 27 April, 2022 at the Westin Fort Lauderdale Beach Resort in Fort Lauderdale, Florida.
The event, compromised of five co-located meetings will explore topics in Clinical and Translational Biophotonics; Microscopy, Histopathology and Analytics; Optical Coherence Tomography; Optical Tomography and Spectroscopy; and Optics and the Brain. Attendees will discover the latest technological solutions to medical challenges and medical applications during the three-day congress. Plenary speakers include Wolfgang Drexler, Medical University of Vienna; Anita Mahadevan-Jansen, Vanderbilt University; Laura Maru, the University of California at Davis; and Daniel Razansky, University of Zurich. The joint plenaries are scheduled for Sunday, 24 April and Tuesday, 26 April, 08:00-09:30 UTC-04:00. Media interviews with the plenary speakers will be facilitated on-site.
“In 2020, we saw that a virtual platform allowed for increased participation from researchers from all across the globe. We are pleased to welcome back our attendees back in person and virtually to lead engaging dialogue in research, innovative new tools and techniques advancing the biomedical optics field,” said Biophotonics Congress Chairs Christine P. Hendon, Columbia University, and Rainer Andreas Leitgeb, Medizinische Universität Wien, Austria.
Wolfgang Drexler, professor and head for the Center for Medical Physics and Biomedical Engineering at the Medical University of Vienna, Vienna, Austria, will discuss disruptive forward-looking innovations and key technologies to further boost OCT performance enabling significantly enhanced medical diagnosis.
Anita Mahadevan-Jansen, professor of biomedical engineering, and recipient of the Orrin H. Ingram chair in biomedical engineering at Vanderbilt University will present the development of label-free spectroscopy and imaging methods including near-infrared autofluorescence for the identification of the parathyroid gland and evaluate its perfusion state during thyroidectomies and parathyroidectomies.
Laura Marcu, professor of biomedical engineering and neurological surgery at the University of California at Davis, will address the development of clinically-compatible multispectral fluorescence lifetime imaging (FLIM) techniques and applications in surgical oncology. Her discussion will examine FLIM’s potential for real-time intraoperative delineation of brain tumors and head-and-neck cancer during robotic surgery.
Daniel Razansky, full professor of biomedical imaging with a double appointment at the Faculty of Medicine, University of Zurich and the Department of Information Technologies and Electrical Engineering of ETH Zurich, where he also serves as director of the joint Preclinical Imaging Center will focus on the latest additions to the arsenal of fluorescence and optoacoustic techniques to enable noninvasive deep tissue imaging of rapid biological dynamics at multiple scales, from single cells to whole organisms.
About Optica
Optica (formerly OSA), Advancing Optics and Photonics Worldwide, is the society dedicated to promoting the generation, application, archiving and dissemination of knowledge in the field. Founded in 1916, it is the leading organization for scientists, engineers, business professionals, students and others interested in the science of light. Optica’s renowned publications, meetings, online resources and in-person activities fuel discoveries, shape real-life applications and accelerate scientific, technical and educational achievement.
